FranckFRahaghiMD

Pulmonology • Weston, FL

Critical Care Medicine, Pleural Disease

Physician

Join to view full profile

Dr. Rahaghi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rahaghi's full profile

Already have an account?

Office
2950 Cleveland Clinic Blvd
Weston, FL 33331
Phone+1 954-659-5000

Fax+1 954-659-5451
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2003
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1997 - 1999
University of MinnesotaInternship, Internal Medicine, 1996 - 1997
University of California San Francisco School of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 2001 - Present
FL State Medical License 2003 - 2025
SC State Medical License 2006 - 2006
NY State Medical License 1999 - 2004
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Top Doctors:South Florida Castle Connolly, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Super Doctor SuperDoctors.com

Clinical Trials

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching Start of enrollment: 2011 Nov 01
Terminated
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Terminated
Phase 2
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Start of enrollment: 2014 May 31
Completed
Phase 2
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Escalating Oral Treprostinil Dose With Intravenous Treprostinil Bridging Therapy.
Vanessa C Perez, Veronica Williams, Franck F Rahaghi> ;Cureus. 2024 Feb 1
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.
Grünig, E., Rahaghi, F., Elwing, J., Vizza, C., Pepke-Zaba, J., Shen, J., Yao, H., Hage, A., Rosenkranz, S., Vonk, M., Balasubramanian, V., Yuanhua, Y., Yu, Z., Lordan...> ;Advances in Therapy. 2024 Feb 1
1 citations
Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil.
John F Kingrey, Chad E Miller, Veronica Franco, Jimmy S Smith, Ronald Zolty, Ronald J Oudiz, Jean M Elwing, Jessica H Huston, Lana Melendres-Groves, Ashwin Ravichandra...> ;Pulmonary Circulation. 2023 Jul 1
2 citations
The role of riociguat in combination therapies for pulmonary arterial hypertension.
Franck F Rahaghi, Maria Giovanna Trivieri, Sandeep Sahay> ;Respiratory Medicine. 2023 May 1
2 citations
Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study.
Huda Asif, Franck F Rahaghi, Akihiro Ohsumi, Julie Philley, Amir Emtiazjoo, Takashi Hirama, Arthur W Baker, Chin-Chung Shu, Fernanda Silveira, Vincent Poulin, Pete Riz...> ;ERJ Open Research. 2023 Mar 1
25 citations
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Franck F Rahaghi, Vivien M Hsu, Robert J Kaner, Maureen D Mayes, Ivan O Rosas, Rajan Saggar, Virginia D Steen, Mary E Strek, Elana J Bernstein, Nitin Bhatt, Flavia V C...> ;Respiratory Research. 2023 Jan 9
Effects of COVID-19 pandemic on the management of pulmonary hypertension.
Christine Y Zhou, Sandeep Sahay, Oksana Shlobin, Francisco J Soto, Stephen C Mathai, Lana Melendres-Groves, Christopher J Mullin, Deborah J Levine, Dana Kay, Kristin H...> ;Respiratory Medicine. 2023 Jan 1
23 citations
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.
Franck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, Joao A de Andrade, Kevin R Flaherty, Lisa H Lancaster, Joyce S Lee, Deborah J Levine, Ioana R Preston, Zeena...> ;Chest. 2022 Jul 1
4 citations
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Franck F Rahaghi, Vijay P Balasubramanian, Robert C Bourge, Charles D Burger, Murali M Chakinala, Michael S Eggert, Jean M Elwing, Jeremy Feldman, Christopher King, Ja...> ;Pulmonary Circulation. 2022 Apr 1
23 citations
Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled Trial.
Robert P. Baughman, Oksana A. Shlobin, Rohit Gupta, Peter J. Engel, Jeffrey I. Stewart, Elyse E. Lower, Franck Rahaghi, Joyce Zeigler, Steven D. Nathan> ;Chest. 2021 Aug 4
11 citations
Alpha-1 antitrypsin deficiency research and emerging treatment strategies: what’s down the road?:
Franck Rahaghi> ;Therapeutic Advances in Chronic Disease. 2021 Jul 29
4 citations
Improving Screening for Alpha-1 Antitrypsin Deficiency with Direct Testing in the Pulmonary Function Testing Laboratory.
Samuel Gurevich, A. Daya, Cristiana Da Silva, Christine Girard, Franck Rahaghi> ;Chronic Obstructive Pulmonary Diseases. 2021 Apr 1
8 citations
Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
Franck Rahaghi, John A. Belperio, John E. Fitzgerald, Mridu Gulati, Robert W. Hallowell, Kristin B. Highland, Tristan J. Huie, Hyun J Kim, Martin Kolb, Joseph A. Lasky...> ;Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine. 2021 Mar 30
2 citations
Urgent Creation of a Palliative Care Team in a Small Hospital During the COVID Crisis.
Nydia Martinez, Hilah Tanev, Samuel Gurevich, Candilla Davis, Mirlande Cazeau, Jinesh Mehta, S. Gillenwater, A. Daya, Franck Rahaghi> ;The American Journal of Hospice & Palliative Care. 2021 Mar 1
1 citations
An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil.
Franck Rahaghi, Roblee P Allen, Vijay Balasubramanian, Murali M. Chakinala, Jean M. Elwing, Jeremy Feldman, Peter J. Leary, Franz Rischard, Zeenat Safdar, Namita Sood,...> ;Pulmonary Pharmacology & Therapeutics. 2021 Feb 1
1 citations
Reducing rates of readmission and development of an outpatient management plan in pulmonary hypertension: lessons from congestive heart failure management.
Justin Dolan, Stacy Mandras, Jinesh Mehta, Viviana Navas, James H. Tarver, Murali M. Chakinala, Franck Rahaghi> ;Pulmonary Circulation. 2020 Dec 7
5 citations
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLB...
Franck Rahaghi, Richard Monk, Viswanathan Ramakrishnan, Tatsiana Beiko, Charlie Strange> ;International Journal of Chronic Obstructive Pulmonary Disease. 2020 Dec 3
4 citations
Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies).
Hossein Ardeschir Ghofrani, Ekkehard Grünig, Pavel Jansa, David Langleben, Stephan Rosenkranz, Ioana R. Preston, Franck Rahaghi, Namita Sood, Dennis Busse, Christian M...> ;Pulmonary Circulation. 2020 Jul 16
7 citations
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fi...
Franck Rahaghi, Zeenat Safdar, Anne Brown, Joao A. de Andrade, Kevin R. Flaherty, Robert J. Kaner, Christopher S. King, Maria L. Padilla, Imre Noth, Mary Beth Scholand...> ;BMC Pulmonary Medicine. 2020 Jul 14
Inpatient Initiation of Oral Treprostinil in an Academic Medical System
Benjamin Hohlfelder, Adriano R. Tonelli, Gustavo A. Heresi, Nancy Bair, Franck Rahaghi, Seth R. Bauer> ;Cardiovascular Drugs and Therapy. 2020 May 19
16 citations
Clinical phenotyping: role in treatment decisions in sarcoidosis.
Robert P. Baughman, Mary Beth Scholand, Franck Rahaghi> ;European Respiratory Review. 2020 Mar 31
67 citations
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis.
Franck Rahaghi, Robert P. Baughman, Lesley Ann Saketkoo, Nadera J. Sweiss, Joseph Barney, Surinder S. Birring, Ulrich Costabel, Elliott D. Crouser, Marjolein Drent, Al...> ;European Respiratory Review. 2020 Mar 31
9 citations
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
Franck Rahaghi, Nadera J. Sweiss, Lesley Ann Saketkoo, Mary Beth Scholand, Joseph Barney, Alicia K. Gerke, Elyse E. Lower, Mehdi Mirsaeidi, Lanier O'Hare, Mark J. Rumb...> ;European Respiratory Review. 2020 Mar 20
2 citations
Real-world experience using combination therapy with riociguat and risk assessment using REVEAL Lite 2.0 in patients with pulmonary arterial hypertension.
Sandeep Sahay, Franck Rahaghi> ;Pulmonary Circulation. 2020 Feb 28
1 citations
Managing the Alpha-1 patient in the ICU: Adapting broad critical care strategies in AATD.
Franck Rahaghi, Laurel Omert, Virginia Clark, Robert A. Sandhaus> ;Journal of Critical Care. 2019 Aug 29
Join now to see all

Press Mentions

United Therapeutics to Feature Clinical Data Across Its Commercial and Development Portfolio at the 2022 American Thoracic Society International ConferenceApril 29th, 2022
Teppanyaki/Hibachi Pneumonitis: An Exotic Cause of Exogenous Lipoid PneumoniaOctober 25th, 2016
Pulmonary Arterial Hypertension: Which Guidelines to Choose?October 14th, 2023
Join now to see all